Payment overview · 2025
General Payments
$75,030.18
172 reported records · 31 companies
Healthcare provider profile · identity verified
Danny Ramzy, MD
Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery) · HOUSTON, TX · NPI 1679723175
Verified facts
What the public records show
CMS Open Payments records show Danny Ramzy, MD received $75,030.18 in general payments during 2025 across 172 reported records.
Arthrex, Inc. accounted for 20.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 46 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Arthrex, Inc. | Unresolved — no canonical attribution shown | $14,991.13 | 20.0% | 7 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$11,472.66 | 15.3% | 14 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $9,502.46 | 12.7% | 32 | 2025 |
| Corcym Inc | Unresolved — no canonical attribution shown | $9,305.49 | 12.4% | 8 | 2025 |
| enableCV Inc. | Unresolved — no canonical attribution shown | $6,900.00 | 9.2% | 1 | 2025 |
| Ethicon Inc. | Unresolved — no canonical attribution shown | $5,920.00 | 7.9% | 2 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $4,621.71 | 6.2% | 18 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $3,396.38 | 4.5% | 24 | 2025 |
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $2,598.33 | 3.5% | 6 | 2025 |
| EnableCV Inc. | Unresolved — no canonical attribution shown | $2,036.99 | 2.7% | 9 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $1,408.07 | 1.9% | 11 | 2025 |
| Teleflex LLC | Unresolved — no canonical attribution shown | $560.85 | 0.8% | 5 | 2025 |
| Artivion, Inc. | Unresolved — no canonical attribution shown | $508.36 | 0.7% | 6 | 2025 |
| Medinc of Texas | Unresolved — no canonical attribution shown | $370.20 | 0.5% | 7 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $308.75 | 0.4% | 3 | 2025 |
| Davol Inc. | Unresolved — no canonical attribution shown | $261.52 | 0.3% | 2 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $166.08 | 0.2% | 1 | 2025 |
| XVIVO Perfusion Inc. | Unresolved — no canonical attribution shown | $138.18 | 0.2% | 1 | 2025 |
| Baxter Healthcare | Unresolved — no canonical attribution shown | $134.75 | 0.2% | 1 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $99.35 | 0.1% | 1 | 2025 |
| Olympus America Inc. | Unresolved — no canonical attribution shown | $58.10 | 0.1% | 2 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $39.38 | 0.1% | 2 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $32.44 | 0.0% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $30.35 | 0.0% | 1 | 2025 |
| Pacira Pharmaceuticals Incorporated | Unresolved — no canonical attribution shown | $29.88 | 0.0% | 1 | 2025 |
| Acera Surgical, Inc. | Unresolved — no canonical attribution shown | $26.65 | 0.0% | 1 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $26.31 | 0.0% | 1 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $24.23 | 0.0% | 1 | 2025 |
| Ethicon US, LLC | Unresolved — no canonical attribution shown | $23.34 | 0.0% | 1 | 2025 |
| On Target Laboratories, Inc | Unresolved — no canonical attribution shown | $23.24 | 0.0% | 1 | 2025 |
| Dilon Technologies, Inc. | Unresolved — no canonical attribution shown | $15.00 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $29,507.50 | 14 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,500.00 | 4 |
| Food and Beverage | $10,992.78 | 137 |
| Travel and Lodging | $6,229.90 | 16 |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,800.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| THRUPORT SYSTEMS INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE Normalized: thruport systems intraclude intra aortic occlusion device |
Device | EnableCV Inc., enableCV Inc. | $8,936.99 | 10 | 2025 |
Source payment records
|
|||||
| AVALUS Normalized: avalus |
Device | Medtronic, Inc. | $8,715.85 | 12 | 2025 |
Source payment records
|
|||||
| PERCEVAL Normalized: perceval |
Device | Corcym Inc | $8,105.49 | 7 | 2025 |
Source payment records
|
|||||
| EPIC Normalized: epic |
Device | Abbott Laboratories | $6,043.48 | 13 | 2025 |
Source payment records
|
|||||
| SIMULUS Normalized: simulus |
Device | Medtronic, Inc. | $2,750.00 | 1 | 2025 |
Source payment records
|
|||||
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $2,598.33 | 6 | 2025 |
Source payment records
|
|||||
| NAVITOR Normalized: navitor |
Device | Abbott Laboratories | $2,445.13 | 6 | 2025 |
Source payment records
|
|||||
| SYNERGY ABLATION SYSTEM Normalized: synergy ablation system |
Device | AtriCure, Inc. | $2,231.92 | 8 | 2025 |
Source payment records
|
|||||
| MEMO 4D Normalized: memo 4d |
Device | Corcym Inc | $1,200.00 | 1 | 2025 |
Source payment records
|
|||||
| ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Normalized: atricure cryoice cryosphere cryoablation system |
Device | AtriCure, Inc. | $1,034.42 | 13 | 2025 |
Source payment records
|
|||||
| MITRIS RESILIA Mitral Valve Normalized: mitris resilia mitral valve |
Device | Edwards Lifesciences Corporation | $883.22 | 9 | 2025 |
Source payment records
|
|||||
| ATRICLIP LAA EXCLUSION SYSTEM Normalized: atriclip laa exclusion system |
Device | AtriCure, Inc. | $722.83 | 7 | 2025 |
Source payment records
|
|||||
| EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Normalized: epi sense guided coagulation system with visitrax |
Device | AtriCure, Inc. | $654.31 | 8 | 2025 |
Source payment records
|
|||||
| MANTA Normalized: manta |
Device | Teleflex LLC | $560.85 | 5 | 2025 |
Source payment records
|
|||||
| ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER Normalized: on x aortic heart valve with conform x sewing ring and extended holder |
Device | Artivion, Inc. | $429.32 | 3 | 2025 |
Source payment records
|
|||||
| MITRACLIP Normalized: mitraclip |
Device | Abbott Laboratories | $403.77 | 5 | 2025 |
Source payment records
|
|||||
| INSPIRIS RESILIA AORTIC VALVE Normalized: inspiris resilia aortic valve |
Device | Edwards Lifesciences Corporation | $345.76 | 3 | 2025 |
Source payment records
|
|||||
| AtriCure cryoICE Cryoablation System (CRYO2) Normalized: atricure cryoice cryoablation system cryo2 |
Device | AtriCure, Inc. | $314.76 | 3 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $308.75 | 3 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $308.75 | 3 | 2025 |
Source payment records
|
|||||
| THORATEC HEARTMATE 3 LVAS IMPLANT KIT Normalized: thoratec heartmate 3 lvas implant kit |
Device | Abbott Laboratories | $302.50 | 4 | 2025 |
Source payment records
|
|||||
| Progel Applicator Spray Tips Normalized: progel applicator spray tips |
Device | Davol Inc. | $261.52 | 2 | 2025 |
Source payment records
|
|||||
| CARDIOMEMS Normalized: cardiomems |
Device | Abbott Laboratories | $259.14 | 2 | 2025 |
Source payment records
|
|||||
| HemoSphere Normalized: hemosphere |
Device | Becton, Dickinson and Company | $166.08 | 1 | 2025 |
Source payment records
|
|||||
| XVIVO Perfusion System (XPS) Normalized: xvivo perfusion system xps |
Device | XVIVO Perfusion Inc. | $138.18 | 1 | 2025 |
Source payment records
|
|||||
| PERCLOT Normalized: perclot |
Device | Baxter Healthcare | $134.75 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $99.35 | 1 | 2025 |
Source payment records
|
|||||
| AMDS-Ascyrus Medical Normalized: amds ascyrus medical |
Device | Artivion, Inc. | $79.04 | 3 | 2025 |
Source payment records
|
|||||
| ENSITE PRECISION Normalized: ensite precision |
Device | Abbott Laboratories | $48.44 | 2 | 2025 |
Source payment records
|
|||||
| 4K Cable 3.0M Normalized: 4k cable 3 0m |
Device | Olympus America Inc. | $39.87 | 1 | 2025 |
Source payment records
|
|||||
| KONECT RESILIA Normalized: konect resilia |
Device | Edwards Lifesciences Corporation | $32.64 | 1 | 2025 |
Source payment records
|
|||||
| CAMZYOS Normalized: camzyos |
Drug | E.R. Squibb & Sons, L.L.C. | $32.44 | 1 | 2025 |
Source payment records
|
|||||
| KEYTRUDA Normalized: keytruda |
Biological | Merck Sharp & Dohme LLC | $30.35 | 1 | 2025 |
Source payment records
|
|||||
| Exparel Normalized: exparel |
Drug | Pacira Pharmaceuticals Incorporated | $29.88 | 1 | 2025 |
Source payment records
|
|||||
| Zilretta Normalized: zilretta |
Drug | Pacira Pharmaceuticals Incorporated | $29.88 | 1 | 2025 |
Source payment records
|
|||||
| Restrata Wound Matrix Normalized: restrata wound matrix |
Device | Acera Surgical, Inc. | $26.65 | 1 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $26.31 | 1 | 2025 |
Source payment records
|
|||||
| ARTEGRAFT VASCULAR GRAFT Normalized: artegraft vascular graft |
Device | LeMaitre Vascular, Inc. | $24.23 | 1 | 2025 |
Source payment records
|
|||||
| PROLENE Normalized: prolene |
Device | Ethicon US, LLC | $23.34 | 1 | 2025 |
Source payment records
|
|||||
| Cytalux Normalized: cytalux |
Drug | On Target Laboratories, Inc | $23.24 | 1 | 2025 |
Source payment records
|
|||||
| GELWEAVE Normalized: gelweave |
Device | Bolton Medical Inc | $19.73 | 1 | 2025 |
Source payment records
|
|||||
| THORAFLEX HYBRID Normalized: thoraflex hybrid |
Device | Bolton Medical Inc | $19.73 | 1 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $19.65 | 1 | 2025 |
Source payment records
|
|||||
| EVIS EXERA III COLONOVIDEOSCOPE Normalized: evis exera iii colonovideoscope |
Device | Olympus America Inc. | $18.23 | 1 | 2025 |
Source payment records
|
|||||
| HEMOBLAST BELLOWS Normalized: hemoblast bellows |
Device | Dilon Technologies, Inc. | $15.00 | 1 | 2025 |
Source payment records
|
|||||
| PENDITURE Normalized: penditure |
Device | Medtronic, Inc. | $6.81 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $75,030.18 · 172 records | Arthrex, Inc. | 4K Cable 3.0M, AMDS-Ascyrus Medical, ARTEGRAFT VASCULAR GRAFT, ATRICLIP LAA EXCLUSION SYSTEM, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, AVALUS, AtriCure cryoICE Cryoablation System (CRYO2), CAMZYOS, CARDIOMEMS, Cytalux, Da Vinci Surgical System, ENDOCROSS Device, ENSITE PRECISION, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, EPIC, EVIS EXERA III COLONOVIDEOSCOPE, Exparel, GELWEAVE, GORE VIABAHN VBX Balloon Expandable Endo, HEMOBLAST BELLOWS, HemoSphere, INSPIRIS RESILIA AORTIC VALVE, KEYTRUDA, KONECT RESILIA, MANTA, MEMO 4D, MITRACLIP, MITRIS RESILIA Mitral Valve, NAVITOR, ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER, PENDITURE, PERCEVAL, PERCLOT, PROLENE, Progel Applicator Spray Tips, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, Restrata Wound Matrix, SIMULUS, SYMPHONY CATHETER, SYNERGY ABLATION SYSTEM, THORAFLEX HYBRID, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, THRUPORT SYSTEMS INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE, Torus Stent Graft System, XVIVO Perfusion System (XPS), Zilretta | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error